Why Suture Selection Matters in Non-Acute Procedural Care
Suture selection influences wound support, tissue response, workflow consistency, and inventory planning in ways that compound across a practice’s procedure volume.
For ASCs, office-based surgery suites, plastic surgery practices, dermatology offices, and wound care settings, the decision is not simply clinical. It affects how efficiently procedures run, how reliably staff can prepare trays, and how consistently supply documentation holds up under audit. Inappropriate selection may contribute to wound dehiscence, prolonged healing, increased tissue reactivity, and patient discomfort.
These are not guaranteed outcomes of any single choice, but they are patterns observed across procedure types when suture properties are mismatched to the clinical context. This guide covers the core distinction between absorbable vs non-absorbable sutures, material properties, selection criteria, evidence context, and inventory and traceability considerations. It is written for licensed clinical operators and procurement leads in non-acute procedural settings.
The Core Distinction: Absorbable vs Non-Absorbable Sutures
Absorbable sutures break down over time through hydrolysis or enzymatic digestion. They do not require removal and are selected when adequate tensile support is needed only through the healing phase.
Non-absorbable sutures remain in tissue unless removed. They provide durable mechanical support and are used when long-term tensile strength is required or when extended wound stability is the priority.
This distinction is the starting point for suture selection. Additional factors — tissue type, healing rate, infection risk, handling characteristics, and needle design — determine the specific material and size within each category.
Absorbable Suture Materials: Properties and Clinical Considerations
Synthetic Absorbable Sutures
Polyglactin 910 (e.g., Vicryl)
Polyglactin 910 is a braided synthetic absorbable suture that absorbs via hydrolysis over approximately 60 to 90 days. Per manufacturer labeling, it retains approximately 65% of tensile strength at two weeks and approximately 40% at three weeks. Tissue reactivity is minimal to moderate. It is commonly used for general soft tissue approximation, subcutaneous closures, and layered wound closure. A coated version reduces tissue drag on passage.
Poliglecaprone 25 (e.g., Monocryl)
Poliglecaprone 25 is a monofilament synthetic suture that absorbs over approximately 90 to 120 days. Tensile strength decreases relatively quickly, with minimal strength remaining by three weeks. Its monofilament structure supports smooth tissue passage and minimal tissue reaction, which may make it suitable for subcuticular closures and cosmetically sensitive areas. Follow manufacturer IFU for knot configuration guidance specific to this material.
Polydioxanone (e.g., PDS)
Polydioxanone is a monofilament synthetic suture with an extended absorption profile of approximately 180 to 210 days. Per manufacturer labeling, it retains approximately 70% of tensile strength at two weeks, 50% at four weeks, and 25% at six weeks. Its extended support profile may benefit fascial closures and slow-healing tissue applications. Handling requires more deliberate knot technique due to higher stiffness relative to braided materials.
Polyglycolic Acid (e.g., Dexon)
Polyglycolic acid is a braided synthetic suture with an absorption profile similar to polyglactin 910. It carries moderate tissue reactivity and may be less appropriate in contaminated wound environments due to its multifilament structure.
Natural Absorbable Sutures
Surgical Gut (Plain and Chromic)
Plain gut absorbs via enzymatic digestion in approximately seven to 10 days. Chromic gut, treated to slow absorption, retains tensile strength for approximately 10 to 14 days. Both carry significant tissue reactivity relative to synthetics. Absorption rate is less predictable than synthetic materials and may vary based on patient factors. Use in mucosal tissues, episiotomy repair, and superficial lacerations where rapid absorption is clinically appropriate.
Non-Absorbable Suture Materials: Properties and Clinical Considerations
Synthetic Non-Absorbable Sutures
Polypropylene (e.g., Prolene)
Polypropylene is a monofilament synthetic suture with minimal tissue reactivity and permanent tensile strength. Its inert properties support vascular anastomoses, skin closures where minimal foreign body response is a priority and hernia repair. Higher memory relative to braided materials may require an adjusted handling technique. Follow IFU for minimum knot throw requirements.
Nylon (e.g., Ethilon, Nurolon)
Nylon is available in monofilament and braided forms. Tensile strength degrades gradually over years per manufacturer data, at approximately 15 to 20% per year for monofilament forms. It is commonly used for skin closures, microsurgery, and ophthalmic applications. Monofilament nylon offers good elasticity and smooth tissue passage with minimal reactivity.
Polyester (e.g., Ethibond, Mersilene)
Polyester is a braided non-absorbable suture with permanent tensile strength and higher tissue reactivity than polypropylene or nylon. Coated versions improve handling. Used in cardiovascular procedures, tendon repair, and orthopedic applications where high knot security and tensile strength are priorities.
Polybutester (e.g., Novafil)
Polybutester is a monofilament non-absorbable suture with elastic properties that allow expansion and recovery with tissue swelling. Used in vascular and plastic surgery applications. Less commonly stocked than polypropylene or nylon.
Natural Non-Absorbable Sutures
Silk
Silk carries significant tissue reactivity and gradual tensile degradation. It offers recognized handling characteristics and knot security and remains in use for ligatures and oral surgery. It has largely been replaced by synthetic alternatives in most wound closure applications.
Surgical Steel
Surgical steel offers maximum tensile strength, minimal tissue reaction, and no degradation. It is used in orthopedic procedures, sternum closure, and high tension abdominal wall closure. Handling is demanding, and fragmentation risk requires careful technique and instrument selection.
Selection Criteria: Matching Suture to Clinical Context
Tissue Type and Healing Timeline
Fast-healing tissues such as skin and subcutaneous layers often accommodate synthetic absorbable materials with shorter tensile retention windows. Slow-healing tissues such as fascia and tendons may require extended-absorption materials or non-absorbable options depending on the load the repair will bear. Avascular and weight-bearing areas require careful attention to how long mechanical support will be needed. A suture that loses tensile strength before the tissue has adequate mechanical integrity may contribute to wound failure.
Construction: Monofilament vs Multifilament
Monofilament sutures pass through tissue without capillary action, which may reduce bacterial harboring in contaminated wound environments. Braided multifilament sutures generally offer better handling, pliability, and knot security, and are often preferred in clean surgical environments where those characteristics take priority.
Infection Risk Context
In contaminated wounds, monofilament synthetic sutures are generally preferred over braided alternatives. Antibacterial-coated sutures warrant evaluation against clinical context and IFU guidance before routine adoption.
Cosmetic and Aesthetic Considerations
In cosmetically sensitive areas, monofilament absorbable sutures such as poliglecaprone used in subcuticular technique may support acceptable cosmetic results with reduced patient burden compared to transcutaneous non-absorbable closure. Early removal of percutaneous sutures in facial repairs — typically three to five days depending on location — is associated with reduced suture mark formation. These are general principles based on published technique literature. Individual results will vary.
Needle Selection
Needle choice is part of suture selection, not separate from it. Taper needles are used in soft tissue where minimal cutting is desired. Cutting needles are used in tough or fibrous tissue. Reverse cutting needles carry the cutting edge on the outer curve to reduce tissue tearing. Blunt-tip needles are used in friable or high-risk tissue such as liver or during procedures with needlestick concern. Review IFU for needle geometry and recommended tissue applications for each product.
Suture Diameter Selection
Suture sizing follows the USP (United States Pharmacopeia) classification system. Larger numbers indicate smaller diameters. The general principle is to select the smallest diameter suture that provides adequate tensile support for the tissue being closed.
| Tissue Location | Recommended Size Range | Notes |
|---|---|---|
| Facial skin | 5-0 to 7-0 | Smaller diameter supports cosmetic outcome |
| Skin, extremities | 3-0 to 5-0 | Balance strength with patient comfort |
| Subcutaneous tissue | 3-0 to 5-0 | Layered support reduces surface tension |
| Fascia | 0 to 2-0 | High tensile strength required |
| Vascular | 5-0 to 8-0 | Minimal wall disruption is the priority |
| Tendon repair | 3-0 to 5-0 | Strength with minimal bulk |
| Ocular tissues | 7-0 to 10-0 | Fine needle control required |
These ranges reflect general published guidance. Specific procedure protocols and institutional practice standards should govern final selection.
Common Clinical Scenarios: Quick Reference
| Clinical Scenario | Primary Suture Option | Alternative | Notes |
|---|---|---|---|
| Facial laceration, superficial | 6-0 nylon or polypropylene | 6-0 fast-absorbing gut | Remove percutaneous sutures at 3-5 days |
| Scalp laceration | 3-0 or 4-0 polypropylene | 3-0 polyglactin | Control hemostasis before closure |
| Trunk or extremity, superficial | 4-0 nylon | 4-0 polypropylene | Standard monofilament closure |
| Oral mucosa | 4-0 chromic gut | 4-0 polyglactin | Absorption avoids removal visit |
| High-tension closure | 3-0 polypropylene with 2-0 PDS deep layer | 3-0 nylon with 2-0 polyglactin deep layer | Layered closure reduces surface tension |
| Contaminated wound | 4-0 monofilament polypropylene | 4-0 monofilament poliglecaprone | Consider delayed primary closure |
| Pediatric facial laceration | 6-0 fast-absorbing gut | 6-0 poliglecaprone | Avoids traumatic removal |
| Abdominal fascial closure | 0 or 1 polydioxanone | 0 polyglactin | Incisional hernia prevention is the priority |
| Vascular anastomosis | 6-0 or 7-0 polypropylene | 6-0 or 7-0 PTFE suture | Permanent, minimally reactive material |
Suture Inventory Standardization for Non-Acute Settings
Most non-acute procedural settings can support the majority of common wound closure needs with a controlled core inventory. Standardizing suture inventory reduces tray preparation variation, supports consistent staff competency, and simplifies expiration tracking and documentation. A representative core inventory for a general office-based or ASC setting might include:
Absorbable
• Polyglactin 910: 2-0, 3-0, 4-0, 5-0
• Poliglecaprone 25: 3-0, 4-0, 5-0
• Polydioxanone: 0, 2-0, 3-0
• Chromic gut: 3-0, 4-0 (where mucosal or rapid-absorption indications exist)
Non-Absorbable
• Polypropylene: 3-0, 4-0, 5-0, 6-0
• Nylon: 3-0, 4-0, 5-0, 6-0
• Silk: 2-0, 3-0 (where indicated)
Specialty procedures will require additional materials outside this core. Expansion decisions should be driven by procedure mix, not inventory breadth for its own sake. Standardization also supports traceability. A smaller, consistent product set makes lot number tracking, expiration management, and recall response more manageable. For a broader look at surgical instrument inventory planning, see our surgical instruments procurement guide.
UDI, Lot Number, and Expiration Documentation
The FDA’s Unique Device Identifier (UDI) system applies to most medical devices, including surgical sutures. The UDI includes a device identifier and, when present on the label, production identifiers such as lot or batch number, serial number, expiration date, and manufacturing date. For each suture product received and used in your practice, staff should:
1. Scan and record the UDI or GS1 barcode at intake
2. Record the lot number, expiration date, and quantity received
3. Log the use location and patient record reference at time of use
4. Store documentation in your inventory management and clinical record systems
This workflow supports three operational requirements: expiration control before use, recall response if a product is flagged after use, and audit-readiness for regulatory or accreditation review. If a suture product fails or contributes to an adverse patient event, report it through FDA MedWatch. MedWatch reporting supports the national safety signal system and is expected when a device is suspected to have contributed to patient harm.
Storage and Handling
Store sterile suture products per manufacturer IFU requirements. Most sutures require protection from excessive heat, humidity, and light. Compromised packaging — including small tears, punctures, or moisture exposure, should result in removal from inventory regardless of expiration date. Designate a specific storage location for suture inventory with clear first-in, first-out rotation. Staff responsible for tray setup should verify expiration date and packaging integrity before opening any suture package. Conduct a documented inventory review at minimum every six months. Record lot numbers, expiration dates, and any items removed from stock.
Procurement and Authorized Sourcing
Suture procurement for licensed non-acute practices should run through authorized distribution channels. Products sourced outside verified channels may lack packaging integrity documentation, cold-chain or storage condition records, or lot traceability.
Pipeline Medical sources suture products through authorized channels and offers a catalog of surgical sutures across common absorbable and non-absorbable categories. Regulatory status — including FDA-cleared, FDA-approved, listed, or otherwise regulated as applicable to the specific product — reflects each item’s classification as documented by the manufacturer. Confirm product-specific status through product documentation.
Our team supports licensed practices in building standardized suture inventories, managing reorder cycles, and maintaining documentation readiness. Procurement through a single verified source simplifies lot tracking, recall response, and audit preparation.
Frequently Asked Questions
What is the difference between absorbable and non-absorbable sutures?
Absorbable sutures break down through hydrolysis or enzymatic digestion over weeks to months, eliminating the need for removal. Non-absorbable sutures remain in tissue unless actively removed. The choice between them depends on how long mechanical wound support is needed and whether suture removal is clinically or operationally appropriate.
Which suture material carries the lowest infection risk?
Monofilament sutures are generally associated with lower bacterial harboring than multifilament alternatives in contaminated environments due to the absence of capillary interstices. Research on triclosan-coated sutures shows some supporting evidence for reduced surgical site infections in select settings, but results are not uniform across trial populations. Follow IFU and established institutional protocols when selecting sutures for contaminated or high-risk wound closure.
What does IFU mean for surgical sutures?
IFU stands for Instructions for Use. The IFU is the manufacturer’s document that specifies the intended use, contraindications, storage conditions, handling guidance, knot requirements, and disposal instructions for a specific suture product. All personnel using surgical sutures should have reviewed the IFU for each product in their regular practice inventory.
How should suture products be documented at time of use?
Record the product name, lot number, size, needle type, and expiration date in the clinical record for each suture used. Capture UDI or GS1 barcode data in your inventory system at intake and cross-reference at use. This supports patient safety, recall traceability, and accreditation documentation requirements.
When should suture use be reported to FDA MedWatch?
If a suture product fails during use, contributes to an adverse outcome, or is suspected to have played a role in patient harm, submit a report through FDA MedWatch. MedWatch is the FDA’s medical product safety reporting program for health professionals, patients, and consumers. Reports support the national safety surveillance system and allow the FDA to identify patterns that may require manufacturer action or safety communication.
How often should suture inventory be audited?
Review suture inventory at minimum every six months. Document lot numbers, expiration dates, packaging condition, and any items removed from stock. First-in, first-out rotation at the storage level reduces the frequency of discovering expired items during procedure prep.
Build a Suture Program That Holds Up to Audit
Suture selection in non-acute procedural settings requires matching material properties to tissue type, healing timeline, infection risk, and procedure context. Absorbable and non-absorbable sutures serve distinct roles, and the choice between them carries downstream effects on wound management, patient experience, and inventory operations.
Standardizing a core suture inventory, documenting UDI and lot data at intake and use, and sourcing through authorized channels are the operational foundations of a well-managed suture program. Browse Pipeline Medical’s surgical suture catalog or contact our team to discuss inventory standardization options for your practice.
Important Safety Note: Surgical sutures are regulated medical devices. Use should follow manufacturer Instructions for Use (IFU), applicable clinical protocols, and scope-of-practice requirements. Suture selection guidance in this article is educational and does not substitute for clinical training, institutional protocol, or direct clinical judgment by a licensed provider. Authorized Sourcing: Pipeline Medical sources suture products through authorized distribution channels. Regulatory status — including FDA-cleared, FDA-approved, listed, or otherwise regulated as applicable to the specific product — reflects each item’s classification as documented by the manufacturer. Confirm product-specific regulatory status through product documentation before procurement decisions.
The information provided on this site is for informational purposes only and is not intended to substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider or medical professional for guidance on any medical concerns, product use, or treatment decisions.